Loss of ARID1A expression is associated with systemic inflammation markers and has important prognostic significance in gastric cancer

被引：0
作者：
Xuan Wang
Keying Che
Tao Shi
Qin Liu
Xinyun Xu
Hongyan Wu
Lixia Yu
Baorui Liu
Jia Wei
机构：
[1] Clinical College of Nanjing Medical University,The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital
[2] Nanjing Medical University,Collaborative Innovation Center for Personalized Cancer Medicine
[3] The Affiliated Hospital of Nanjing University Medical School and Clinical Cancer Institute of Nanjing University,The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital
[4] The Affiliated Drum Tower Hospital of Nanjing University Medical School,Department of Pathology
来源：
Journal of Cancer Research and Clinical Oncology | 2022年 / 148卷
关键词：
Gastric cancer; Systemic inflammation markers; Immunotherapy; Nomogram;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1583 / 1595
页数：12
相关论文
共 50 条
  • [1] Loss of ARID1A expression is associated with systemic inflammation markers and has important prognostic significance in gastric cancer
    Wang, Xuan
    Che, Keying
    Shi, Tao
    Liu, Qin
    Xu, Xinyun
    Wu, Hongyan
    Yu, Lixia
    Liu, Baorui
    Wei, Jia
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (07) : 1583 - 1595
  • [2] Loss of ARID1A expression is associated with poor prognosis in patients with gastric cancer
    Zhu, Yi Ping
    Sheng, Li Li
    Wu, Jing
    Yang, Mo
    Chen, Xian Feng
    Wu, Ning Ni
    Ye, Xiao Bing
    Cai, Juan
    Wang, Lu
    Shen, Qian
    Wu, Jian Qiu
    HUMAN PATHOLOGY, 2018, 78 : 28 - 35
  • [3] Functional loss of ARID1A is tightly associated with high PD-L1 expression in gastric cancer
    Kim, Young-Bae
    Ahn, Ji Mi
    Bae, Won Jung
    Sung, Chang Ohk
    Lee, Dakeun
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (04) : 916 - 926
  • [4] The clinical significance of ARID1A mutations in gastric cancer patients
    Wu, Chia-Hung
    Tseng, Chien-Hsun
    Huang, Kuo-Hung
    Fang, Wen-Liang
    Chen, Ming-Huang
    Li, Anna
    Wu, Chew-Wun
    FORMOSAN JOURNAL OF SURGERY, 2020, 53 (03) : 93 - +
  • [5] Loss of ARID1A, ARID1B, and ARID2 Expression During Progression of Gastric Cancer
    Aso, Tatsuya
    Uozaki, Hiroshi
    Morita, Shigeki
    Kumagai, Arisa
    Watanabe, Masato
    ANTICANCER RESEARCH, 2015, 35 (12) : 6819 - 6827
  • [6] Various ARID1A expression patterns and their clinical significance in gastric cancers
    Kim, Young-Bae
    Ham, In-Hye
    Hur, Hoon
    Lee, Dakeun
    HUMAN PATHOLOGY, 2016, 49 : 61 - 70
  • [7] The effects of ARID1A mutation in gastric cancer and its significance for treatment
    Lu, Shan
    Duan, Ruifeng
    Cong, Liang
    Song, Ying
    CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [8] The effects of ARID1A mutation in gastric cancer and its significance for treatment
    Shan Lu
    Ruifeng Duan
    Liang Cong
    Ying Song
    Cancer Cell International, 23
  • [9] ARID1A mutation/ARID1A loss is associated with a high immunogenic profile in clear cell ovarian cancer
    Kuroda, Yuka
    Chiyoda, Tatsuyuki
    Kawaida, Miho
    Nakamura, Kohei
    Aimono, Eriko
    Yoshimura, Takuma
    Takahashi, Mio
    Saotome, Keiko
    Yoshihama, Tomoko
    Iwasa, Naomi
    Sakai, Kensuke
    Yamagami, Wataru
    Nishihara, Hiroshi
    Aoki, Daisuke
    GYNECOLOGIC ONCOLOGY, 2021, 162 (03) : 679 - 685
  • [10] The clinical significance of PD-L1 in advanced gastric cancer is dependent on ARID1A mutations and ATM expression
    Buglioni, Simonetta
    Melucci, Elisa
    Sperati, Francesca
    Pallocca, Matteo
    Terrenato, Irene
    De Nicola, Francesca
    Goeman, Frauke
    Casini, Beatrice
    Amoreo, Carla Azzurra
    Gallo, Enzo
    Diodoro, Maria Grazia
    Pescarmona, Edoardo
    Vici, Patrizia
    Sergi, Domenico
    Pizzuti, Laura
    Di Lauro, Luigi
    Mazzotta, Marco
    Barba, Maddalena
    Fanciulli, Maurizio
    Vitale, Ilio
    De Maria, Ruggero
    Ciliberto, Gennaro
    Maugeri-Sacca, Marcello
    ONCOIMMUNOLOGY, 2018, 7 (08):
12345